•
PM
PMVP
PMV Pharmaceuticals, Inc
polygonPHARMACEUTICAL PREPARATIONS
--
Price Chart
Market Cap
57.47M
Volume
683.85K
52W High
$1.84
52W Low
$0.81
Open
$1.11
Prev Close
$1.08
Day Range
1.05 - 1.11
About PMV Pharmaceuticals, Inc
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.
Latest News
Here's Why PMV Pharmaceuticals (PMVP) Could be Great Choice for a Bottom Fisher
Zacks Investment Research•Jun 3
Foundation Medicine and PMV Pharma Announce Collaboration to Develop Companion Diagnostic for Rezatapopt, a First-In-Class, Investigational, Selective p53 Y220C Reactivator
GlobeNewswire Inc.•May 29
Here's Why You Should Buy Acrivon Therapeutics (ACRV) Stock
Zacks Investment Research•May 28
PMV Pharmaceuticals PYNNACLE Phase I Data of Rezatapopt in Advanced Ovarian Cancer Featured in Late-Breaking Oral Presentation at 2024 SGO Annual Meeting on Women’s Cancer
GlobeNewswire Inc.•Mar 18
PMV Pharmaceuticals Reports Full Year 2023 Financial Results and Corporate Highlights
GlobeNewswire Inc.•Feb 29
PMV Pharmaceuticals Announces Prioritization of PC14586 Clinical Development and Extended Cash Runway
GlobeNewswire Inc.•Jan 18
PMV Pharmaceuticals Strengthens Leadership with Key Appointments as Company Advances into Late-Stage Development
GlobeNewswire Inc.•Jan 5
PMV Pharmaceuticals, Inc. (PMVP) Loses -70.19% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Zacks Investment Research•Oct 16